Quidel Receives FDA Clearance for Its New Solana® Molecular Assay for the Detection of Group B Streptococcal Infections
22 December 2017
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has received 510(k) clearance from the Unit